SynCardia Systems, Inc.

/**/ P { margin-bottom: 0.08in; } /**/

SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart for use as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.

Content from this campaign

Health & Healthcare
SynCardia Provides Update Regarding Voluntary Recall of Potentially Affected Freedom® Portable Drivers
SynCardia Systems, Inc. today provided an update regarding the resolution of a recent voluntary recall of a limited number of its Freedom® portable drivers, following a related U.S. Food and Drug Administration (FDA) September 18, 2015 recall announcement.
Health & Healthcare
SynCardia Provides Update Regarding Voluntary Recall of Potentially Affected Freedom® Portable Drivers
SynCardia Systems, Inc. today provided an update regarding the resolution of a recent voluntary recall of a limited number of its Freedom® portable drivers, following a related U.S. Food and Drug Administration (FDA) September 18, 2015 recall announcement.
Health & Healthcare
Dan Hudspeth Joins SynCardia Systems, Inc. as Chief Financial Officer

More from SynCardia Systems, Inc.

SynCardia Awards and Recognition

SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE...

SynCardia Systems, Inc.

SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE...

Artificial Heart

For patients suffering from end-stage biventricular (both sides) heart failure, a donor heart transplant is the standard of care. However, not all...